###begin article-title 0
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 154 154 154 154 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 154 154 154 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 154 154 154 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
Identification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory Protein*
###end article-title 0
###begin p 1
Upon virus infection, the cell mounts an innate type I interferon (IFN) response to limit the spread. This response is orchestrated by the constitutively expressed IFN regulatory factor (IRF)-3 protein, which becomes post-translationally activated. Although the activation events are understood in detail, the negative regulation of this innate response is less well understood. Many viruses, including Kaposi sarcoma-associated herpesvirus (KSHV), have evolved defense strategies against this IFN response. Thus, KSHV encodes a viral IRF (vIRF)-2 protein, sharing homology with cellular IRFs and is a known inhibitor of the innate IFN response. Here, we show that vIRF-2 mediates IRF-3 inactivation by a mechanism involving caspase-3, although vIRF-2 itself is not pro-apoptotic. Importantly, we also show that caspase-3 participates in normal IRF-3 turnover in the absence of vIRF-2, during the antiviral response induced by poly(I:C) transfection. These data provide unprecedented insight into negative regulation of IRF-3 following activation of the type I IFN antiviral response and the mechanism by which KSHV vIRF-2 inhibits this innate response.
###end p 1
###begin p 2
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN3"><sup>2</sup></xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
The earliest response at the cellular level to virus infection is the establishment of the antiviral state that results from induction of type I interferon (IFN)2 expression. The objective of this antiviral state is containment of the virus infection and elimination of the infected cell. It operates in multiple ways, including inhibiting cell growth by blocking proliferation and modulating apoptosis, and augmenting adaptive immunological surveillance and responses (see Ref. 1). Sensing of the virus infection to initiate the antiviral response occurs in different ways, in part depending upon whether the virus enters the cell by endocytosis or by fusion with the plasma membrane. One of the most important components transducing these virus-sensing signals is IFN regulatory factor (IRF)-3. It participates in transcribing genes that contribute to establishing the antiviral state.
###end p 2
###begin p 3
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 406 407 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 409 410 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 667 668 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 670 671 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 805 806 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
Upon virus infection, IRF-3 is post-translationally modified by C-terminal phosphorylation by a "virus-activated kinase" (2, 3) that promotes translocation of the protein from the cytoplasm to the nucleus. There, it is assimilated into the IFN-beta enhancesome, a multiprotein complex that facilitates transcription of IFN and IFN-responsive genes. This enhancesome, whose structure is well characterized (4, 5), represents the paradigm for understanding the molecular basis behind regulation of gene transactivation in response to virus infection. The components of virus-activated kinase that phosphorylate IRF-3 include IkappaB kinase-Ïµ and TANK-binding kinase-1 (6, 7). Depending on the pathway leading to IRF-3 activation, other kinases may also participate, including phosphatidylinositol 3-kinase (8).
###end p 3
###begin p 4
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Although post-translational activation of IRF-3 is understood in detail, less is known of its deactivation that negatively regulates the type I IFN response. Until now, only phosphorylation-dependent ubiquitination of IRF-3, leading to its proteasomal degradation has been recognized. Hiscott and colleagues showed that C-terminal phosphorylation of IRF-3 is necessary for degradation and is followed by Cullin1 interaction, ubiquitination, and proteasomal degradation (9; see Ref. 10). Poly-ubiquitination and concomitant degradation of IRF-3 are regulated by the peptidylprolyl isomerase Pin-1 (11).
###end p 4
###begin p 5
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 753 755 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 362 390 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Inhibiting the IFN antiviral response is an important component of the biology of many viruses (1). Studying the molecular interactions of viruses with the immune system, including their strategies of evasion, has provided deeper understanding of its operation. Recent examples set a precedent in the context of the innate immune system. First, the study of the human immunodeficiency virus Vif protein identified a new innate immune response to retroviruses (12) mediated by the cellular protein, CEM15 or APOBEC3G, a DNA deaminase, which destroys or mutates the virus genome (13). Second, the recognition through its binding to paramyxovirus V proteins that mda-5 is a central player in the signal transduction cascade leading to IFN-beta expression (14).
###end p 5
###begin p 6
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 347 350 <span type="species:ncbi:9606">men</span>
Through studying modulation of the IFN response by Kaposi sarcoma-associated herpesvirus (KSHV), we now demonstrate a unique cellular mechanism inhibiting IRF-3 function by a caspase-3-dependent process. KSHV is the etiologic agent of the most common malignancy affecting AIDS patients, Kaposi sarcoma (KS), which is also the most common tumor of men in certain African countries (15). Approximately one quarter of the KSHV genome encodes proteins with either demonstrated or putative immunomodulatory activity (16), and one of these viral genes encodes the vIRF-2 protein (17), which inhibits the type I IFN response to viral infection (18, 19, 20). Here, using a model system of activation of the antiviral response by transfection of synthetic double-stranded RNA, we have identified a novel caspase-3-dependent turnover of cellular IRF-3 that is involved in the normal negative feedback loop to help terminate the antiviral response. This caspase-3-dependent mechanism is targeted by vIRF-2 to accelerate cellular IRF-3 turnover and thereby down-modulate the antiviral response.
###end p 6
###begin title 7
EXPERIMENTAL PROCEDURES
###end title 7
###begin title 8

###end title 8
###begin title 9

###end title 9
###begin title 10
Reagents
###end title 10
###begin p 11
Poly(I:C), MG132, and etoposide were obtained from Sigma-Aldrich, and Z-VAD-FMK was from Calbiochem. SYTO(R) 16 green-fluorescent nucleic acid stain was a generous gift of Gemma Kelly.
###end p 11
###begin title 12
Cell Culture
###end title 12
###begin p 13
###xml 170 176 <span type="species:ncbi:9913">bovine</span>
###xml 308 314 <span type="species:ncbi:9913">bovine</span>
HEK293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with non-essential amino acids, penicillin, and streptomycin and 10% heat-inactivated fetal bovine serum. MCF-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with penicillin and streptomycin and 10% fetal bovine serum.
###end p 13
###begin title 14
Plasmid Constructs and Site-directed Mutagenesis
###end title 14
###begin p 15
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 602 604 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 657 664 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
Full-length KSHV vIRF-2 cDNA was subcloned into the pcDNA4/HisMax expression vector as previously described (20). The resulting vIRF-2 protein contains contiguous N-terminal polyhistidine and XpressTM epitope tags and is referred to as Xpress-tagged vIRF-2. The caspase-3 (pcDNA3/caspase-3) and FLAG epitope-tagged IRF-3 wild-type (IRF-3WT) (21) expression plasmids were kindly provided by Reiner U. Janicke and John Hiscott, respectively. The p125-luc luciferase plasmid contains the full-length IFN-beta promoter upstream of the firefly luciferase gene and was generously provided by Takashi Fujita (22). Firefly luciferase levels were normalized against Renilla luciferase constitutively expressed from the co-transfected plasmid pRLSV40 (Stratagene).
###end p 15
###begin p 16
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
To mutate the serine and threonine residues in the C-terminal region of IRF-3 to alanine, site-directed mutagenesis was performed with the QuikChangeTM system (Stratagene), according to the manufacturer's instructions. Thus, to generate the 2A(S385/386A), 5A(ST396/398/402/404/405AA), and 2A5A constructs, PCR was performed with the following primers: 2A(S385/386A), 5'-GGGTGCCGCCGCCCTGGAG-3' and 5'-CTCCAGGGCGGCGGCACCC-3'; 5A(ST396/398/402/404/405AA), 5'-CATTGCCAACGCCCACCCACTCGCCCTCGCCGCCGACC-3' and 5'-GGTCGGCGGCGAGGGCGAGTGGGTGGGCGTTGGCAATG-3'. The 2A5A mutant was derived with the 2A PCR primers on the 5A mutant. All constructs were verified by sequencing.
###end p 16
###begin title 17
Transient Transfections
###end title 17
###begin p 18
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Transfections were performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions on 75% confluent HEK293 or MCF-7 cells grown in 6-well plates. Plasmid quantities were: FLAG-tagged IRF-3WT or mutant expression plasmids (300 ng/well), pcDNA3/caspase-3 expression plasmid (300 ng/well), pcDNA4/vIRF-2 expression plasmid (500 ng/well), p125-luc (100 ng/well), and pRLSV40 (5 ng/well). The corresponding empty vectors were added to equalize DNA concentration (see Ref. 20).
###end p 18
###begin title 19
Cell Treatments
###end title 19
###begin p 20
###xml 12 13 11 12 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 34 35 32 33 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 349 350 338 339 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 474 475 461 462 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
MG132 (10 mum) or Z-VAD-FMK (10 mum) treatment (30 min, 37 degreesC) was performed 24 h following plasmid transfection. Negative controls were treated with the equivalent volume of DMSO. Next, without changing the medium, the cells were transfected with poly(I:C) (10 mug/ml). Caspase-3 knockdown was performed with caspase-3 ShortCut(R) siRNA (25 nm, New England Biolabs); the corresponding negative control was the nonspecific Lit28i Polylinker ShortCut(R) siRNA mix (25 nm, New England Biolabs). Plasmid transfection was performed at the same time, as required. Twenty-four hours later, transfection with poly(I:C) (10 mug/ml) was performed as necessary.
###end p 20
###begin title 21
Western Blot Analysis
###end title 21
###begin p 22
###xml 52 53 52 53 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 75 76 75 76 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 86 87 86 87 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 97 98 97 98 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 153 154 153 154 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 337 338 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1054 1056 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 896 907 <span type="species:ncbi:3704">horseradish</span>
Cell pellets were suspended in lysis buffer E (100 mm Tris-HCl, pH 8, 100 mm NaCl, 2 mm EDTA, 2 mm EGTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.5 mm phenylmethylsulfonyl fluoride, mini protease inhibitor mixture (Roche Diagnostic)). After incubation (10 min, 4 degreesC), insoluble material was removed by centrifugation (16,000 x g, 5 min, 4 degreesC). The protein concentration was determined by the Bradford dye-binding procedure (Bio-Rad Laboratories), and 35 mug of total protein was separated by SDS-PAGE on 12% acrylamide gels. Proteins were transferred to Immobilon-P transfer membrane (Millipore) that was then blocked in Tris-buffered saline containing 0.02% Tween-20 (TBS-T) and nonfat milk (5%) and probed with primary antibodies diluted in TBS-T containing 5% nonfat milk as described below. Bands were visualized by probing with appropriate secondary antibodies conjugated to horseradish peroxidase (DAKO) and performing enhanced chemiluminescence. Native PAGE was performed essentially according to the protocol of a previous study (23).
###end p 22
###begin title 23
Antibodies for Western Blot and Immunoprecipitation
###end title 23
###begin p 24
###xml 558 560 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Primary antibodies were used at the following dilutions and incubation conditions: anti-Pro-caspase-3 polyclonal antibody (Cell Signaling Technologies) diluted 1:5,000 and incubated for 18 h at 4 degreesC; anti-poly(ADP-ribose) polymerase monoclonal antibody (Sigma-Aldrich) diluted 1:5,000 and incubated for 18 h at 4 degreesC; anti-phospho-IRF-3 (Ser396) polyclonal antibody (Upstate) diluted 1:5,000 and incubated for 18 h at 4 degreesC; anti-FLAG(R) M2 monoclonal antibody (Sigma-Aldrich) diluted 1:50,000 and incubated for 1 h at 4 degreesC; anti-XpressTM monoclonal antibody (Invitrogen) diluted 1:5,000 and incubated for 1 h at 4 degreesC; anti-beta-actin monoclonal antibody (Sigma-Aldrich) diluted 1:50,000 and incubated for 1 h at 4 degreesC; anti-IRF-3 monoclonal antibody (Abcam) diluted 1:100 and incubated for 2 h at 4 degreesC; and for denaturing gels IRF-3 was detected with anti-IRF-3(FL-425) polyclonal antibody (Santa Cruz Biotechnology) diluted 1:1000 and incubated 1 h at 4 degreesC.
###end p 24
###begin title 25
Co-immunoprecipitation
###end title 25
###begin p 26
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 682 700 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Cell lysates were prepared in buffer E, as described above. They were pre-cleared by incubation with protein G-Sepharose 4B fast flow (Sigma-Aldrich) or protein A-Sepharose 4B fast flow (Sigma-Aldrich), and supernatants were collected by centrifugation (16,000 x g, 1 min, 4 degreesC). They were then incubated with either 1 mug of anti-Xpress (90 min) or 1 mul of anti-procaspase-3 antibodies (16 h) at 4 degreesC. Immunoprecipitation was performed with either protein G- or protein A-Sepharose beads, and proteins were analyzed by Western blot. Negative control immunoprecipitations were performed on cells transfected with the plasmid pCEP4-SM (1 mug) expressing the FLAG-tagged Epstein-Barr virus protein BSLF2/BMLF, a generous gift of Martin Rowe.
###end p 26
###begin title 27
Transient Transfections and Luciferase Assays in HEK293 and MCF-7 Cells
###end title 27
###begin p 28
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Dual luciferase assays were performed according to a previous study (20).
###end p 28
###begin title 29
Quantification of Apoptosis
###end title 29
###begin p 30
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Apoptosis was quantified by flow cytometry on cells stained with Syto-16 and propidium iodide according to the method of a previous study (24). Data for approximately25,000 cells were collected for each treatment condition.
###end p 30
###begin title 31
Caspase Activity Assay
###end title 31
###begin p 32
Caspase activity was measured with the Caspase-Glo(R)-3/7 assay kit (Promega) that makes use of the luminogenic caspase-3/-7 substrate Z-DEVD-aminoluciferin. Measurements were performed according to the manufacturer's instructions.
###end p 32
###begin title 33
Confocal Microscopy
###end title 33
###begin p 34
###xml 667 673 <span type="species:ncbi:9913">bovine</span>
###xml 777 783 <span type="species:ncbi:9913">bovine</span>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
###xml 934 938 <span type="species:ncbi:9925">goat</span>
###xml 974 980 <span type="species:ncbi:9986">rabbit</span>
###xml 1271 1276 <span type="species:ncbi:10090">mouse</span>
###xml 1374 1378 <span type="species:ncbi:9925">goat</span>
###xml 1431 1437 <span type="species:ncbi:9986">rabbit</span>
MCF-7 cells were plated on coverslips in 24-well plates. The next day, they were transfected with expression vectors for FLAG-tagged IRF-3 wild-type (IRF-3WT), or Xpress-tagged vIRF-2 (vIRF-2) or caspase-3, as required. The vIRF-2 protein is dually tagged with both Xpress and His epitopes. Twenty-four hours later, cells were transfected with poly(I:C) (10 mug/ml) for 16 h, as required. The cells were fixed with a final concentration of 2% of formaldehyde solution (methanol-free, Pierce) added directly to the medium for 20 min at room temperature. After fixation, the cells were washed three times (PBS, 15 min, room temperature) and were then permeabilized (2% bovine serum albumin, 0.5% Triton X-100 in PBS, 10 min, at room temperature) and blocked (blocking buffer: 2% bovine serum albumin, 0.1% Triton X-100 in PBS, 60 min at room temperature). Primary antibodies were mouse anti-His (Sigma-Aldrich, 1/100) to detect vIRF-2, goat anti-IRF-3 (RandD, 10 mug/ml), and rabbit anti-caspase-3 (AbCam) diluted 1/50. All primary antibody incubations were performed in blocking buffer overnight at 4 degreesC. After primary antibody incubation, cells were washed (PBS, four times for 15 min, at room temperature) and incubated with appropriate secondary antibodies: anti-mouse AlexaFluor(R)-555 (Invitrogen, 1/500 dilution, kindly provided by Dr. Claire Shannon-Lowe), anti-goat AlexaFluor(R)-633 (Invitrogen, diluted 1/100), anti-rabbit-fluorescein isothiocyanate (Sigma-Aldrich, at 1/100 dilution). All secondary antibody incubations were performed in blocking buffer for 1 h at room temperature. Cells were then washed (PBS, four times for 15 min, at room temperature) and incubated with 4',6-diamidino-2-phenylindole (1/1000 in PBS, 5 min, at room temperature). The coverslips were mounted with ProLong(R) Gold Antifade reagent (Molecular Probes, Invitrogen).
###end p 34
###begin title 35
Establishment of the Clone #3-9 Cell Line Stably Transfected with an Inducible vIRF-2 Expression Cassette
###end title 35
###begin p 36
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
The vIRF-2 gene was subcloned in-frame into the doxycycline-inducible expression vector pTRE2-pur-Myc (Clontech), creating a 5'-Myc-labeled vIRF-2 derivative. This plasmid was transfected into HEK293-Tet-On cells (Clontech) that stably express the tetracycline-regulated transactivator rtTA. From these cells, a clonal puromycin-resistant cell line was derived with minimal basal vIRF-2 expression; it is referred to as "clone #3-9." A negative control cell line ("Empty Vector" (EV)), isogenic to clone 3-9 cells except that it lacked vIRF-2, was established in the same way.
###end p 36
###begin title 37
Measuring Endogenous IRF-3 Activation
###end title 37
###begin p 38
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Active endogenous IRF-3 was measured by TransAMTM IRF-3 transcription factor ELISA (Active Motif) that was performed according to the manufacturer's directions. Nuclear extracts for this assay were prepared with the Nuclear Extract Kit (Active Motif).
###end p 38
###begin title 39
RESULTS
###end title 39
###begin title 40

###end title 40
###begin title 41

###end title 41
###begin title 42
KSHV vIRF-2 Represses IFN-beta Promoter Transactivation and Reduces Wild-type IRF-3 Protein Levels
###end title 42
###begin p 43
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 671 677 665 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 677 678 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 680 691 674 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 927 929 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1029 1031 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Ectopic expression studies of vIRF-2 were performed to investigate the function of the vIRF-2 protein without confounding its activity by the presence of other KSHV immunomodulatory proteins. Thus, the cDNA encoding the spliced vIRF-2 gene was cloned into the pcDNA4/HisMax vector (Invitrogen) to generate pcDNA/vIRF-2 expressing the full-length vIRF-2 protein containing contiguous N-terminal polyhistidine and Xpress epitope tags (20). When measuring the activity of the full-length IFN-beta promoter of the transiently co-transfected reporter plasmid p125-luc, vIRF-2 inhibited IFN-beta promoter transactivation by wild-type FLAG-tagged IRF-3 (IRF-3WT), by up to 70% (Fig. 1A, upper panel). In this model system, the antiviral response and IRF-3 phosphorylation are activated by transfection of synthetic double-stranded RNA (poly(I:C)), as opposed to using the constitutively active phosphomimetic IRF-3 mutant, IRF-3(5D) (21). These data are consistent with our previous findings on vIRF-2 inhibition of IRF-3(5D) function (20).
###end p 43
###begin p 44
###xml 0 110 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KSHV vIRF-2 expression represses IFN-&#946; promoter transactivation and reduces wild type IRF-3 protein levels.</bold>
###xml 114 115 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 117 128 114 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 619 626 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1009 1010 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1029 1030 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1038 1048 1029 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">White bars</italic>
###xml 1089 1098 1080 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gray bars</italic>
###xml 1132 1142 1123 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black bars</italic>
###xml 1192 1203 1183 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower panel</italic>
###xml 1352 1353 1343 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1926 1927 1910 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 2029 2030 2013 2014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2090 2091 2074 2075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2108 2109 2092 2093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 2142 2143 2126 2127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2339 2340 2323 2324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 2581 2583 2565 2567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 2602 2604 2586 2588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</italic>
###xml 2624 2626 2608 2610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</italic>
###xml 2646 2650 2630 2634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A5A</italic>
###xml 2672 2674 2656 2658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 2715 2717 2699 2701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IB</italic>
###xml 2749 2752 2733 2736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IgG</italic>
###xml 2854 2859 2838 2843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Input</italic>
###xml 2867 2872 2851 2856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes</italic>
###xml 2971 2972 2955 2956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
KSHV vIRF-2 expression represses IFN-beta promoter transactivation and reduces wild type IRF-3 protein levels. In A: upper panel: transcriptional activity of the full-length IFN-beta promoter (p125-luc) reporter vector. HEK293 cells were transiently co-transfected with p125-luc and an expression plasmid of either FLAG epitope-tagged IRF-3 wild type (IRF-3WT), or the mutants IRF-3(2A), IRF-3(5A), and IRF-3(2A5A). Each transfection also included the Xpress epitope-tagged vIRF-2-expressing plasmid, pcDNA4/vIRF-2 (vIRF-2), or the empty parental plasmid backbone, pcDNA4. The pRLSV40 plasmid constitutively expressing Renilla luciferase was added as an internal control to which firefly luciferase levels were normalized. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml), and luciferase activity was measured 18 h later. All reporter assays were repeated at least three times and mean values (+/- S.D.) are presented from one representative experiment (**, p < 0.01, Student's t test). White bars, cells lacking ectopic IRF-3 or vIRF-2; gray bars, cells expressing ectopic IRF-3; black bars, cells co-transfected to express ectopic vIRF-2. Lower panel: the IRF-3 C-terminal phosphorylation sites 1 and 2 (amino acids 382 to 414) are presented with the identities of the serine/threonine substitutes. B, vIRF-2 expression reduces total phosphorylated IRF-3 levels. Lysates were prepared from HEK293 cells that had been transfected with the IRF-3WT expression vector and either the vIRF-2 expression vector or the empty vector control (pcDNA4). Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C). They were then harvested at the times indicated and separated by SDS-PAGE and immunoblotted with the following antibodies: anti-phospho-IRF-3 (alpha-p-IRF-3; Ser396), anti-Xpress (vIRF-2), anti-FLAG (total ectopic IRF-3) and anti-beta-actin. C, vIRF-2 expression reduces both monomeric and dimeric IRF-3 levels. Lysates prepared as described in B were separated by native PAGE to detect the IRF-3 dimeric (D) and monomeric (M) forms with anti-FLAG antibody. D, interaction of vIRF-2 with IRF-3. Co-immunoprecipitation studies were performed with lysates of HEK293 cells that had been transfected with the expression plasmids and poly(I:C) as described in A. vIRF-2 was immunoprecipitated with anti-Xpress monoclonal antibody. Immunoprecipitates and input extracts were separated by SDS-PAGE before immunoblotting with anti-FLAG polyclonal antibody to detect IRF-3 or anti-Xpress to detect vIRF-2. WT, IRF-3 wild type; 2A, IRF-3(2A) mutant; 5A, IRF-3(5A) mutant; 2A5A, IRF-3(2A5A) mutant; IP, antibody used for immunoprecipitation; IB, antibody used for immunoblot. IgG, provides a measure ensuring equal loading of immunoprecipitate between lanes; heavy chain is shown. Input, these lanes demonstrate the expression levels for vIRF-2 and IRF-3 in the lysates before immunoprecipitation. E, IRF-3(5A) accumulates in the presence of vIRF-2. HEK293 cells were transfected with FLAG-tagged IRF-3(5A)-expression vector in the presence and absence of the Xpress-tagged vIRF-2 expression vector and transfected with poly(I:C) 24 h later. After incubating for the times indicated, protein extracts were prepared and analyzed by SDS-PAGE and immunoblot.
###end p 44
###begin p 45
###xml 23 29 23 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 345 351 345 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 354 365 354 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 635 643 635 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en masse</italic>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Because these studies (Fig. 1A, upper panel) were performed by activating IRF-3WT with transfection of poly(I:C), the influence of IRF-3 phosphorylation on the control of transactivation by vIRF-2 was investigated. IRF-3 phosphorylation occurs predominantly within two C-terminal domains, sites 1 and 2, containing serine/threonine-rich tracts (Fig. 1A, lower panel) and is essential for the activity of the protein. Although some debate continues as to the precise function of phosphorylation of specific residues within these sites (see Refs. 10, 25), a detailed understanding of the significance of phosphorylation of sites 1 and 2 en masse exists. Thus, IRF-3 autoinhibition is repressed by phosphorylation of the seven serine and threonine residues in these sites that induces a structural change releasing the N terminus and allowing the protein to homodimerize, interact with the transcriptional coactivator CBP/p300, and participate in assembly of the enhancesome (21, 26). Specifically, phosphorylation within IRF-3 site 2 represses autoinhibition, permitting interaction with CBP/p300, and facilitating phosphorylation within site 1 that then enables homodimerization (25).
###end p 45
###begin p 46
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 147 153 147 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 156 167 156 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 313 319 301 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 319 320 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 322 333 310 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 389 391 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 530 536 515 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 536 537 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 539 550 524 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 552 553 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 572 573 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 834 840 819 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 840 841 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 843 854 828 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 902 904 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
Sites 1 and 2 were mutated separately and together, creating two previously described IRF-3 mutants (21, 27) 2A and 5A and the double mutant 2A5A (Fig. 1A, lower panel). As expected, the inherent transactivation capacity of the 5A mutant, IRF-3(5A), was reduced by approximately50% compared with that of IRF-3WT (Fig. 1A, upper panel), consistent with its reduced dimerization capability (27). vIRF-2 reproducibly reduced IRF-3(5A) transactivation of the IFN-beta promoter slightly, but not by a statistically significant amount (Fig. 1A, upper panel; p > 0.05, Student's t test). These data suggest vIRF-2 inhibition of IRF-3 transactivation depends on cognate phosphorylation of residues at IRF-3 C-terminal site 2. Neither the 2A mutant, IRF-3(2A), nor the double mutant, IRF-3(2A5A), possess significant transactivation activity (Fig. 1A, upper panel), consistent with their inability to dimerize (27), and therefore the impact of vIRF-2 on their function is indeterminable.
###end p 46
###begin p 47
###xml 257 263 257 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 266 277 266 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 9</italic>
###xml 353 355 353 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</italic>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4</italic>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 655 661 655 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 661 662 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 664 675 664 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 965 971 962 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 971 972 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
Quantifying the temporal amounts of phosphorylated IRF-3 revealed they were reduced in the presence of vIRF-2. Thus, 18 h after activating the antiviral response by poly(I:C) transfection, phosphorylated IRF-3 levels were reduced in the presence of vIRF-2 (Fig. 1B, upper panel, compare the level of phospho-IRF-3 in the presence of vIRF-2, lanes 9 and 10, with that in the absence of vIRF-2, lanes 4 and 5). Total IRF-3 levels, detected with anti-FLAG antibody, were likewise also reduced to some extent, and this finding was confirmed by non-denaturing gel analyses that revealed vIRF-2 reduced both dimeric (phosphorylated) and monomeric IRF-3 levels (Fig. 1C, upper panel). Repeating these studies up to 48 h post-activation of the antiviral response with poly(I:C) transfection provided further evidence that vIRF-2 reduced IRF-3 levels (data not shown). Thus, these data correlate vIRF-2-mediated inhibition of IRF-3 transactivation of the IFN-beta promoter (Fig. 1A) with reduced amounts of phosphorylated IRF-3, following poly(I:C) activation of the antiviral response.
###end p 47
###begin p 48
###xml 273 279 273 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 519 525 519 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 528 537 528 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 547 554 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 675 681 675 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 684 693 684 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 703 710 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 5</italic>
###xml 715 716 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 774 780 774 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 783 792 783 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 794 800 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 4</italic>
Given these findings, the physical interaction of vIRF-2 and IRF-3 was investigated. vIRF-2 was immunoprecipitated, and the products were analyzed for the presence of IRF-3 by Western blot. Only IRF-3WT and IRF-3(5A) co-precipitated with vIRF-2 to any demonstrable extent (Fig. 1D). Indeed, the amount of IRF-3WT co-precipitating was always less than that of IRF-3(5A). Furthermore, activation of the antiviral response by poly(I:C) transfection consistently reduced the amount of IRF-3WT co-precipitating with vIRF-2 (Fig. 1D, top panel, compare lanes 1 and 2), whereas the level of co-precipitating IRF-3(5A) was unaffected or even increased following poly(I:C) treatment (Fig. 1D, top panel, compare lanes 5 and 6). The faint band appearing in the presence of IRF-3(2A) (Fig. 1D, top panel, lane 4) is a nonspecific protein of lower molecular size than IRF-3.
###end p 48
###begin p 49
###xml 14 20 14 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 23 34 23 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4</italic>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 139 145 139 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 148 159 148 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;4</italic>
###xml 429 435 429 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 438 450 438 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
###xml 452 459 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 5</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 484 491 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1</italic>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 799 805 796 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 805 806 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 808 819 805 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 876 885 873 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 5&#8211;8</italic>
###xml 913 922 910 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;4</italic>
Like IRF-3WT (Fig. 1B, upper panel, lanes 4 and 5), IRF-3(5A) gradually accumulated after poly(I:C) transfection in the absence of vIRF-2 (Fig. 1E, upper panel, lanes 1-4), most likely as a consequence of phosphorylation within C-terminal site 1. The absolute levels are lower than for IRF-3WT, because the mutant protein is expressed less efficiently than the wild type (compare "input levels" detected by anti-FLAG antibody in Fig. 1D, bottom panel, lanes 5 and 6 for IRF-3(5A) and lanes 1 and 2 for IRF3WT). However, this mutant, whose transactivation of the IFN-beta promoter is not significantly inhibited by vIRF-2, but which binds this viral protein, is not depleted from the cell in the presence of the viral protein, unlike IRF-3WT. Rather, IRF-3(5A) accumulates in the presence of vIRF-2 (Fig. 1E, upper panel, compare the IRF-3(5A) level in the presence of vIRF-2, lanes 5-8, with that in its absence, lanes 1-4).
###end p 49
###begin p 50
How might vIRF-2 cause the selective turnover of IRF-3WT? Multiple processes, enzymes, and subcellular components drive cellular protein turnover. They include calpain, autophagy, and the proteasome. The stability of IRF-3 in the presence of vIRF-2 was not affected by treatment with a specific inhibitor of calpain (calpain inhibitor I, data not shown), nor by an activator of autophagy (rapamycin, data not shown).
###end p 50
###begin title 51
The Accelerated Decay of Activated IRF-3WT by vIRF-2 Is Independent of the Proteasome
###end title 51
###begin p 52
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 165 192 <span type="species:ncbi:11099">bovine viral diarrhea virus</span>
###xml 225 245 <span type="species:ncbi:10320">bovine herpesvirus 1</span>
The proteasome degrades poly-ubiquitinated proteins. Indeed, as a strategy to evade induction of the innate antiviral response, viruses as diverse as the flavivirus bovine viral diarrhea virus (28), having an RNA genome, and bovine herpesvirus 1 (29) with a DNA genome, can accelerate the decay of IRF-3 by augmenting its poly-ubiquitination and proteasomal degradation (see Ref. 1).
###end p 52
###begin p 53
###xml 151 157 151 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 160 169 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 202 211 202 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 265 274 265 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;3</italic>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Proteasome degradation is inhibited by treatment with MG132. As expected, treating cells with MG132 stabilized IRF-3 following poly(I:C) transfection (Fig. 2A, top panel, compare the amount of IRF-3 in lanes 4-6 in the presence of MG132 with that in its absence in lanes 1-3; see also supplemental Figs.  and (i)). These data confirm that IRF-3 can be the target of a proteasome-dependent degradative process, as previously reported (9).
###end p 53
###begin p 54
###xml 0 140 0 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The accelerated decay of activated wild-type IRF-3 by vIRF-2 is independent of the proteasome, but inhibited by a general caspase inhibitor.</bold>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 348 358 348 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 374 385 374 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 597 598 596 597 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 985 988 980 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top</italic>
###xml 990 995 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel</italic>
###xml 1052 1059 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1</italic>
###xml 1060 1066 1055 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-18. B</italic>
###xml 1139 1144 1134 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z-VAD</italic>
###xml 1248 1249 1243 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1319 1320 1313 1314 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1341 1351 1335 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 1461 1462 1454 1455 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1489 1490 1481 1482 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1508 1509 1499 1500 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1512 1523 1503 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 1694 1699 1682 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Un-Cl</italic>
###xml 1736 1743 1724 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cleaved</italic>
The accelerated decay of activated wild-type IRF-3 by vIRF-2 is independent of the proteasome, but inhibited by a general caspase inhibitor.A, vIRF-2-accelerated decay of wild-type IRF-3 is independent of the proteasome. HEK293 cells were transiently co-transfected with expression vectors for either FLAG epitope-tagged wild type IRF-3 (IRF-3WT) (left panel) or IRF-3(5A) (right panel) and either Xpress epitope-tagged vIRF-2, or the empty parental plasmid backbone, pcDNA4. Twenty-four hours later, cells were treated for 30 min with either DMSO (as the vehicle negative control) or MG132 (10 mum) and then transfected with poly(I:C) (10 mug/ml). Lysates were prepared at various times thereafter, and protein samples were separated by SDS-PAGE and immunoblotted with anti-FLAG (to detect IRF-3), anti-Xpress (to detect vIRF-2), and anti-beta-actin antibodies. This experiment is representative of more than three performed independently. A longer exposure of the anti-FLAG (IRF-3) (top) panel is presented in , to confirm IRF-3 can be visualized in lanes 12-18. B, vIRF-2-accelerated decay of wild-type IRF-3 is repressed by Z-VAD-FMK (Z-VAD) treatment, which inhibits caspase activity. This experiment was repeated essentially as described for A, with the exception that the cells were treated with Z-VAD-FMK (10 mum) in place of MG132 (left panel) and the IRF-3(5A) expression plasmid was not used. Alternatively, cells were treated with DMSO, MG132 (10 mum), or both Z-VAD-FMK (10 mum) and MG132 (10 mum) (right panel). Immunoblotting was performed with anti-FLAG (IRF-3), anti-Xpress (vIRF-2), anti-PARP, and anti-beta-actin antibodies. The anti-PARP antibody recognizes uncleaved PARP (Un-Cl, 116 kDa) and one cleaved fragment (Cleaved, 83 kDa). This experiment is representative of more than three performed independently.
###end p 54
###begin p 55
###xml 35 41 35 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B&#8211;E</italic>
###xml 107 113 107 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 116 125 116 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 158 167 158 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;3</italic>
###xml 285 295 285 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 8&#8211;10</italic>
###xml 467 473 467 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 476 487 476 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 521 532 521 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 12&#8211;15</italic>
###xml 607 616 607 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;7</italic>
###xml 713 719 713 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 719 720 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 855 861 855 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 864 875 864 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 913 924 913 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 19&#8211;21</italic>
###xml 1045 1056 1045 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 27&#8211;29</italic>
Consistent with the previous data (Fig. 1, B-E), the level of IRF-3 was reduced in the presence of vIRF-2 (Fig. 2A, top panel, compare the amount of IRF-3 in lanes 1-3 in the presence of DMSO and absence of vIRF-2 with that in the presence of both DMSO and vIRF-2 at the same times in lanes 8-10; see also (ii)). However, importantly and remarkably, IRF-3 turnover was dramatically accelerated in the presence of vIRF-2 and MG132 compared with the absence of vIRF-2 (Fig. 2A, upper panels, compare the amount of IRF-3 in lanes 12-15 in the presence of MG132 and vIRF-2 with that in the absence of vIRF-2 in lanes 4-7). Under the same conditions, the IRF-3(5A) mutant, which accumulates in the presence of vIRF-2 (Fig. 1E), also accumulated in the presence of MG132, and even more so in the presence of both the proteasome inhibitor and the viral protein (Fig. 2A, upper panels, compare the amount of IRF-3(5A) in lanes 19-21 in the presence of MG132 and absence of vIRF-2, with that in the presence of both MG132 and vIRF-2 at the same times in lanes 27-29; see also (iii)).
###end p 55
###begin p 56
These data suggested vIRF-2 might recruit, to fully activated IRF-3WT, either a protein or a protein complex responsible for IRF-3 decay and perhaps normally targeted for degradation by the proteasome, but stabilized in the presence of MG132. In contrast, IRF-3(5A), lacking phosphorylation at C-terminal site 2, resists this degradative process.
###end p 56
###begin p 57
To determine if vIRF-2 enhanced IRF-3 ubiquitination and thereby degradation by the proteasome, the extent of poly-ubiquitination of IRF-3 in the presence of vIRF-2 was measured. No effect of the viral protein could be determined (data not shown).
###end p 57
###begin title 58
The Accelerated Decay of Activated IRF-3WT Is Inhibited by a General Caspase Inhibitor
###end title 58
###begin p 59
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 330 330 330 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31"/>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 629 631 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 762 764 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Another class of enzymes involved in proteolysis is the caspases, cysteine-dependent proteases that cleave substrates after an aspartate residue. They function during apoptosis, a homeostatic mechanism of programmed cell death. However, caspases are increasingly recognized as functioning in the absence of apoptosis (see Refs. 30-32). For example, caspase-3 was recently implicated in promoting stem cell development (33, 34). Caspase-8 and -10 participate in signaling by the RNA helicases RIG-I and mda-5 following stimulation with double-stranded RNA, and they drive inflammatory cytokine production by activating NF-kappaB (35). Caspase-8 and -10 are initiator caspases that generally activate the effector caspases, such as caspase-3, -6, and -7 (see Ref. 32).
###end p 59
###begin p 60
###xml 242 248 242 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 251 260 251 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 320 329 320 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;3</italic>
###xml 365 374 365 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 637 643 637 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 646 655 646 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 738 747 738 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
###xml 807 818 807 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
To determine if caspases might be responsible for vIRF-2-mediated turnover of IRF-3, their activity was suppressed by treatment with a general inhibitor (Z-VAD-FMK). Even in the presence of Z-VAD-FMK and absence of vIRF-2, IRF-3 accumulated (Fig. 2B, top panel, compare the level of IRF-3 in the absence of Z-VAD-FMK in lanes 1-3 with the levels in its presence in lanes 4-6; see also (i)). These data suggest that one or more caspases is responsible in part for IRF-3 turnover in the normal cell in which the antiviral response has been invoked by poly(I:C) transfection. IRF-3 also accumulated in the presence of Z-VAD-FMK and vIRF-2 (Fig. 2B, top panel, compare the level of IRF-3 in the absence of Z-VAD-FMK and presence of vIRF-2 in lanes 7-9 with the levels in the presence of Z-VAD-FMK and vIRF-2 in lanes 10-12; see also (ii)).
###end p 60
###begin p 61
###xml 119 125 119 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 128 137 128 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 12</italic>
###xml 187 193 187 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 196 205 196 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 273 281 273 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 17</italic>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 433 439 433 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
The pronounced accelerated decay of IRF-3 identified in the presence of MG132 and vIRF-2 after poly(I:C) transfection (Fig. 2A, top panel, lanes 12-15) was also inhibited with Z-VAD-FMK (Fig. 2B, top panel, compare the level of IRF-3 in the presence of vIRF-2 and MG132 in lanes 17-20 with the level in the presence of vIRF-2, MG132 and Z-VAD-FMK in lanes 21-24; see also (iii)). These data suggest that, when vIRF-2 binds to IRF-3 (Fig. 1D), it might recruit a caspase that then contributes to the decay of IRF-3.
###end p 61
###begin p 62
###xml 114 120 114 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 153 164 153 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
###xml 178 187 178 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 327 333 327 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 336 347 336 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21&#8211;24</italic>
###xml 411 417 411 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 420 429 420 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13&#8211;16</italic>
IRF-3 levels in the presence of Z-VAD-FMK and vIRF-2 did not reach those seen in the presence of Z-VAD-FMK alone (Fig. 2B, compare the level of IRF-3 in lanes 10-12 with that in lanes 4-6; see also (v)), presumably because caspase inhibition by Z-VAD-FMK was not absolute. vIRF-2 also accumulated in the presence of Z-VAD-FMK (Fig. 2B, lanes 10-12 and 21-24) compared with the absence of the caspase inhibitor (Fig. 2B, lanes 7-9 and 13-16; see also (iv)), suggesting the viral protein is a target of one or more caspases.
###end p 62
###begin p 63
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 577 583 577 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 586 593 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 823 829 823 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 829 830 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 832 843 832 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 18&#8211;20</italic>
###xml 906 912 906 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 912 913 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 915 926 915 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 22&#8211;24</italic>
###xml 998 1004 998 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1004 1005 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1055 1062 1055 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 1067 1068 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 1099 1106 1099 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 8</italic>
###xml 1108 1109 1108 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 1111 1113 1111 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</italic>
###xml 1119 1121 1119 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</italic>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
The stabilization of IRF-3 levels by Z-VAD-FMK treatment, despite the presence of vIRF-2, raised the possibility that this viral protein may be pro-apoptotic and that it was reducing IRF-3 levels as a consequence of activating apoptosis. To investigate this possibility, lysates of cells with and without vIRF-2 were assayed for a hallmark indicator of apoptosis: cleavage of poly(adenosine diphosphate-ribose) polymerase (PARP). PARP is a target of mature caspase-3 cleavage (36). As expected, low levels of cleaved PARP could be detected in cells transfected with poly(I:C) (Fig. 2B, lanes 2 and 3), because part of the antiviral response is to induce apoptosis (1), and IRF-3 can participate in this induction independently of its role in the IFN response (37, 38). PARP cleavage was elevated following MG132 treatment (Fig. 2B, lanes 18-20), and this cleavage was reduced by the addition of Z-VAD-FMK (Fig. 2B, lanes 22-24). However, PARP cleavage was not elevated by the expression of vIRF-2 (Fig. 2B, compare PARP cleavage in the absence of vIRF-2, lanes 2 and 3, with that in its presence in lanes 8, 9, 15, and 16), indicating the viral protein is not pro-apoptotic, as suggested previously (39). Further evidence excluding vIRF-2 from a pro-apoptotic role was obtained by quantifying apoptosis in transfected cells by flow cytometry ().
###end p 63
###begin title 64
The Accelerated Decay of Activated IRF-3WT by vIRF-2 Depends on Caspase-3 Activity
###end title 64
###begin p 65
###xml 332 338 332 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 587 593 584 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 593 594 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 649 653 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 655 656 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</italic>
###xml 662 663 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 789 795 783 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 795 796 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 851 855 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 857 858 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 864 865 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 1140 1146 1128 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1146 1147 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1157 1161 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 1163 1164 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 1170 1171 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 1216 1222 1204 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1222 1223 1210 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1320 1326 1308 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1326 1327 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1329 1338 1317 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 1398 1407 1386 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;3</italic>
###xml 1442 1451 1430 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
Because Z-VAD-FMK is a pan-caspase inhibitor, the identity of the caspase most likely involved in IRF-3 decay was sought. Studies with caspase-specific inhibitors indicated that IRF-3 decay was reduced when caspase-3 activity was inhibited. Indeed, when functional levels of caspase-3 were knocked down by >50% with specific siRNA (Fig. 3A), IRF-3WT-mediated transactivation of the IFN-beta promoter in reporter gene assays was increased significantly in the presence of vIRF-2. Thus, under these circumstances, inhibition of IRF-3 transactivation by vIRF-2 was significantly mitigated (Fig. 3B, compare the normalized IFN-beta promoter activity in bars #7 and #8). However, mitigation was not complete, as compared with the level of promoter activity achieved with caspase-3 siRNA alone (Fig. 3B, compare the normalized IFN-beta promoter activity in bars #8 and #5), suggesting vIRF-2 inhibits IRF-3 activity by another, caspase-3-independent, mechanism. Furthermore, IRF-3 transactivation of the IFN-beta promoter, even in the absence of vIRF-2, was increased significantly in the presence of caspase-3 siRNA compared with control siRNA (Fig. 3B, compare bars #5 and #4, respectively). These data confirm those of Fig. 2B: that IRF-3WT turnover was reduced in the presence of Z-VAD-FMK, even in the absence of vIRF-2 (Fig. 2B, top panel, compare the level of IRF-3 in the absence of Z-VAD-FMK in lanes 1-3 with the level in its presence in lanes 4-6; see also (i)). They therefore provide evidence in support of a cellular mechanism in which caspase-3 participates to turnover IRF-3 following activation of the antiviral response by poly(I:C) transfection. vIRF-2 accelerates this process.
###end p 65
###begin p 66
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The accelerated decay of activated wild-type IRF-3 by vIRF-2 depends on caspase-3 activity.</bold>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 309 322 305 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control siRNA</italic>
###xml 356 367 350 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3 siRNA</italic>
###xml 605 606 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 625 626 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 634 635 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1009 1016 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1143 1156 1129 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control siRNA</italic>
###xml 1173 1178 1159 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 1485 1486 1468 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1492 1493 1475 1476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1503 1504 1486 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1523 1524 1506 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1532 1541 1515 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gray bars</italic>
###xml 1575 1585 1558 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black bars</italic>
###xml 1635 1636 1618 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1927 1940 1910 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control siRNA</italic>
###xml 1957 1962 1940 1945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 2246 2252 2228 2234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 2280 2288 2258 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-p-IRF-3</italic>
###xml 2370 2375 2345 2350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Un-Cl</italic>
###xml 2412 2419 2387 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cleaved</italic>
###xml 2508 2509 2483 2484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2667 2674 2642 2649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT</italic>
###xml 2706 2712 2681 2687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 2819 2820 2793 2794 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 3049 3050 3020 3021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3069 3070 3040 3041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 3078 3088 3049 3059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Black bars</italic>
###xml 3138 3139 3109 3110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 3188 3199 3159 3170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Upper panel</italic>
###xml 3361 3368 3332 3339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT</italic>
###xml 3396 3402 3367 3373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 3740 3751 3710 3721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 3841 3851 3807 3817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Pro-cas-3</italic>
###xml 3854 3856 3820 3822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PE</italic>
###xml 3875 3877 3841 3843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT</italic>
###xml 4022 4037 3988 4003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all seven lanes</italic>
###xml 4123 4135 4089 4101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2 lanes</italic>
###xml 4173 4184 4139 4150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">intervening</italic>
###xml 4186 4202 4152 4168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">irrelevant lanes</italic>
###xml 4232 4234 4198 4200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 4275 4277 4241 4243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IB</italic>
###xml 4309 4320 4275 4286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right panel</italic>
###xml 4322 4327 4288 4293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Input</italic>
###xml 4335 4340 4301 4306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes</italic>
The accelerated decay of activated wild-type IRF-3 by vIRF-2 depends on caspase-3 activity.A, siRNA knockdown of caspase-3. Functional levels of caspase-3 protein were analyzed with the Caspase-Glo(R)-3/7 assay kit (Promega). HEK293 cells were transfected with either Lit28i Polylinker ShortCut(R) siRNA mix (Control siRNA) or caspase-3 ShortCut(R) siRNA (CAS-3 siRNA) for 24 h. They were then transfected with poly(I:C) for 18 h before harvesting for caspase activity assay. Activity assays were repeated at least twice, and average values (+/- S.D.) are presented from one representative experiment (*, p < 0.05, Student's t test). B, knockdown of caspase-3 elevates IFN-beta promoter-driven reporter gene activity. HEK293 cells were transiently co-transfected with the full-length IFN-beta promoter reporter plasmid (p125-luc) and an expression vector of FLAG-tagged IRF-3 wild-type (IRF-3WT), or Xpress-tagged vIRF-2-expression vector (vIRF-2), as indicated. The pRLSV40 plasmid constitutively expressing Renilla luciferase was added as an internal control to which firefly luciferase levels were normalized. Co-transfection with control (Control siRNA) and caspase-3 (CAS-3) siRNA was performed as indicated. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml), and luciferase activity was measured 18 h later. Average values (+/- S.D.) are presented from one representative experiment of at least three performed independently (*, #, and + indicate p < 0.05, Student's t test). Gray bars, cells expressing ectopic IRF-3; black bars, cells co-transfected to express ectopic vIRF-2. C, knockdown of caspase-3 elevates phospho-IRF-3 levels. HEK293 cells were transiently co-transfected with an expression vector for FLAG-tagged IRF-3 wild-type (IRF-3WT), and Xpress-tagged vIRF-2 (vIRF-2) or empty vector parental plasmid (pcDNA4), as indicated. Co-transfection with control (Control siRNA) and caspase-3 (CAS-3) siRNA was performed as indicated. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml). Protein extracts were prepared at the indicated times thereafter and analyzed by immunoblot with the following antibodies: anti-PARP, anti-Xpress (vIRF-2), anti-phospho-IRF-3 (alpha-p-IRF-3; Ser-396) and anti-beta-actin. The anti-PARP antibody recognizes uncleaved PARP (Un-Cl, 116 kDa) and one cleaved fragment (Cleaved, 83 kDa). This experiment is representative of more than three performed independently. D, expression of vIRF-2 influences caspase-3/-7 activity. HEK293 cells were transiently transfected with an expression vector for FLAG-tagged IRF-3 wild type (IRF-3WT), and/or Xpress-tagged vIRF-2 (vIRF-2), as indicated. Twenty-four hours after plasmid transfection, the cells were treated with etoposide (50 mum) or DMSO and 30 min later transfected with poly(I:C) (10 mug/ml). Caspase-3/-7 activities were measured 18 h later. Average values (+/- S.D.) are presented from one representative experiment of three performed independently (*, p < 0.05, Student's t test). Black bars, cells co-transfected to express ectopic vIRF-2. E, pro-caspase-3 interacts with IRF-3 and vIRF-2. Upper panel: co-immunoprecipitation studies were performed with lysates of HEK293 cells that had been transfected with an expression vector for FLAG-tagged IRF-3 wild-type (IRF-3WT), or Xpress-tagged vIRF-2 (vIRF-2), as indicated. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml), and immunoprecipitation assays were performed 18 h later. Wild-type IRF-3 was immunoprecipitated with anti-FLAG polyclonal antibody and vIRF-2 with anti-Xpress monoclonal antibody. Immunoprecipitates and input extracts (lower panel) were separated by SDS-PAGE before immunoblotting with anti-Pro-caspase-3 antibody (alpha-Pro-cas-3). PE, protein extract; NT, non-transfected cells. Plasmid pCEP-4 expresses a negative control FLAG-tagged protein that did not immunoprecipitate pro-caspase-3. Note that all seven lanes were separated on the same gel and transferred to the same membrane, but because the vIRF-2 lanes were not contiguous with the others, intervening, irrelevant lanes were removed from the image. IP, antibody used for immunoprecipitation; IB, antibody used for immunoblot. Right panel, Input: these lanes demonstrate the expression levels for vIRF-2, IRF-3 and pro-caspase-3 in the lysates before immunoprecipitation.
###end p 66
###begin p 67
###xml 94 100 91 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 100 101 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 103 106 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 108 109 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 204 210 201 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 210 211 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 213 222 210 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 292 301 289 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 346 355 343 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 1&#8211;3</italic>
###xml 506 512 503 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 512 513 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 515 524 512 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 605 616 602 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
###xml 672 681 669 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
Elevated IRF-3WT transactivation of the IFN-beta promoter in the presence of caspase-3 siRNA (Fig. 3B, bar #5) was mirrored by the relative accumulation of phosphorylated IRF-3 under the same conditions (Fig. 3C, top panel, compare the phospho-IRF-3 level in the presence of caspase-3 siRNA, lanes 4-6 with that in the presence of control siRNA, lanes 1-3; see also (i)). Likewise, phospho-IRF-3 levels accumulated in the presence of vIRF-2 and caspase-3 siRNA when compared with vIRF-2 and control siRNA (Fig. 3C, top panel, compare the phospho-IRF-3 level in the presence of caspase-3 siRNA and vIRF-2, lanes 10-12 with that in the presence of vIRF-2 and control siRNA, lanes 7-9; see also (ii)). This increase in phospho-IRF-3 levels resulting from caspase-3 siRNA treatment in the presence of vIRF-2 was not as exaggerated as that in the absence because complete caspase-3 knockdown was not achieved and therefore active caspase-3 continued contributing to IRF-3 turnover in a mechanism accelerated by vIRF-2.
###end p 67
###begin p 68
###xml 86 92 86 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 5</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 145 151 145 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 261 267 261 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 8</italic>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 402 408 402 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 8</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</italic>
###xml 523 525 523 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</italic>
###xml 857 863 857 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 863 864 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 866 869 866 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 925 931 925 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 931 932 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 934 937 934 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 939 940 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
As expected, reduced cleavage of PARP was evident in the presence of caspase-3 siRNA (Fig. 3C, lanes 5 and 6), when compared with control siRNA (Fig. 3C, lanes 2 and 3). Cleaved PARP levels were also reduced in the presence of vIRF-2 compared with its absence (Fig. 3C, compare lanes 8 and 9 with lanes 2 and 3), regardless of the presence of caspase-3 siRNA. This finding is consistent with that from Fig. 2B (compare PARP cleavage in the absence of vIRF-2, lanes 2 and 3, with that in its presence in lanes 8, 9, 15, and 16) and suggests vIRF-2 might have either anti-apoptotic activity or sequester caspase-3 away from PARP, or both. Therefore, these data are also consistent with those indicating vIRF-2 is not pro-apoptotic (). Furthermore, vIRF-2 significantly reduced caspase-3/-7 activities following poly(I:C) treatment in the presence of IRF-3WT (Fig. 3D, bar #9), compared with the level in the absence of vIRF-2 (Fig. 3D, bar #5).
###end p 68
###begin p 69
###xml 18 24 18 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B&#8211;D</italic>
###xml 401 407 401 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 540 546 540 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 606 612 606 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 645 654 645 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
###xml 687 698 687 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
Thus, the data of Fig. 3 (B-D) suggest an interaction between activated IRF-3WT and caspase-3, and between vIRF-2 and caspase-3. To determine if this interaction is physical, pro-caspase-3 was immunoprecipitated and the presence of IRF-3WT and vIRF-2 determined by Western blot. Both proteins co-precipitated with pro-caspase-3. However, the level of vIRF-2 was reduced following poly(I:C) treatment (Fig. 3E), consistent with this viral protein being either a direct or indirect target of caspase-3 activity, as suggested from the data of Fig. 2B in which vIRF-2 accumulated in the presence of Z-VAD-FMK (Fig. 2B, compare vIRF-2 levels between lanes 7-9 in the absence of Z-VAD-FMK and lanes 10-12 in its presence; see also (iv)).
###end p 69
###begin title 70
IRF-3WT Accumulates in a Caspase-3-deficient Cell Line Unless Ectopic Caspase-3 Is Introduced, when vIRF-2 Accelerates IRF-3WT Decay
###end title 70
###begin p 71
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 356 362 353 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 362 363 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 373 377 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 379 380 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 386 387 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 555 561 552 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 561 562 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 564 567 561 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 569 570 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 692 698 686 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 698 699 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 709 713 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 715 716 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 722 723 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 774 780 768 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 780 781 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 783 786 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 788 789 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 889 895 883 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 895 896 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 898 901 892 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 903 904 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 994 1000 988 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1000 1001 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1003 1006 997 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 1008 1009 1002 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 1133 1139 1127 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1139 1140 1133 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 159 164 <span type="species:ncbi:9606">human</span>
Because knockdown studies with siRNA did not completely abrogate caspase-3 activity, the transactivating function and fate of IRF-3WT were investigated in the human breast adenocarcinoma cell line, MCF-7, which is caspase-3-deficient (40). First, the full-length IFN-beta reporter plasmid was found to be significantly activated by poly(I:C) transfection (Fig. 4A, compare bars #1 and #2), confirming the function of the antiviral response signaling pathway in this cell line. This activation was increased significantly by ectopic expression of IRF-3WT (Fig. 4A, bar #3). The introduction of caspase-3 into these cells reduced IRF-3WT transactivation of the IFN-beta promoter significantly (Fig. 4A, compare bars #3 and #4), to that level resulting from vIRF-2 expression (Fig. 4A, bar #5). The expression of caspase-3 and vIRF-2 together synergistically reduced IRF-3WT transactivation (Fig. 4A, bar #6). The inhibition of IRF-3WT transactivation by vIRF-2, despite the absence of caspase-3 (Fig. 4A, bar #5) indicates that the viral protein also inhibits IRF-3 activity in a caspase-3-independent manner, as suggested previously (Fig. 3B).
###end p 71
###begin p 72
###xml 0 129 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT accumulates in a caspase-3-deficient cell line unless ectopic caspase-3 is introduced, when vIRF-2 accelerates the decay.</bold>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 342 350 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p125-luc</italic>
###xml 410 417 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT</italic>
###xml 445 451 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 505 510 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 587 594 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 923 924 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 932 933 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 952 953 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1003 1013 994 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">White bars</italic>
###xml 1054 1063 1045 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gray bars</italic>
###xml 1097 1107 1088 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black bars</italic>
###xml 1157 1158 1148 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1319 1326 1310 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT</italic>
###xml 1354 1360 1345 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vIRF-2</italic>
###xml 1414 1419 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 1523 1524 1514 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1949 1950 1937 1938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1952 1953 1940 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1972 1973 1960 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1981 1991 1969 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Black bars</italic>
IRF-3WT accumulates in a caspase-3-deficient cell line unless ectopic caspase-3 is introduced, when vIRF-2 accelerates the decay.A, IFN-beta promoter-driven reporter gene activity is elevated in the absence of caspase-3. Caspase-3-deficient MCF-7 cells were transiently co-transfected with the full-length IFN-beta promoter reporter plasmid (p125-luc) and an expression vector for FLAG-tagged IRF-3 wild type (IRF-3WT), or Xpress-tagged vIRF-2 (vIRF-2) or pcDNA3/caspase-3, a caspase-3 expression vector (CAS-3), as indicated in the figure. The pRLSV40 plasmid constitutively expressing Renilla luciferase was added as an internal control to which firefly luciferase levels were normalized. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml), and luciferase activity was measured 18 h later. Average values (+/- S.D.) are presented from one representative experiment (â, *, #, and + p < 0.05, Student's t test) of at least three performed independently. White bars, cells lacking ectopic IRF-3 or vIRF-2; gray bars, cells expressing ectopic IRF-3; black bars, cells co-transfected to express ectopic vIRF-2. B, IRF-3WT accumulates in a caspase-3-deficient cell line. MCF-7 cells were transiently co-transfected with an expression vector for FLAG-tagged IRF-3 wild-type (IRF-3WT), or Xpress-tagged vIRF-2 (vIRF-2) or pcDNA3/Caspase-3, a caspase-3 expression vector (CAS-3) or the empty vector pcDNA4, as indicated in the figure. Protein extracts were analyzed by immunoblot. C, vIRF-2 sequesters caspase-3 activity. Caspase-3/7 activity was measured in MCF-7 cells transfected with plasmids described above, as indicated in the figure. Twenty-four hours after plasmid transfection, the cells were transfected with poly(I:C) (10 mug/ml). Caspase-3/-7 activities were measured 18 h later. Average values (+/-S.D.) are presented from one representative experiment of three performed independently (* and #, p < 0.05, Student's t test). Black bars, cells co-transfected to express ectopic vIRF-2.
###end p 72
###begin p 73
###xml 115 121 112 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 121 122 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 300 306 285 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 306 307 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 309 315 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 6</italic>
###xml 372 378 357 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 378 379 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 381 387 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 3</italic>
###xml 544 550 529 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 550 551 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 553 560 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 12</italic>
These effects on IRF-3WT transactivation of the IFN-beta promoter were mirrored directly by the levels of IRF-3WT (Fig. 4B). In particular, within 24 h of poly(I:C) transfection of MCF-7 cells already transfected with the caspase-3 expression vector, IRF-3WT levels were reduced by approximately60% (Fig. 4B, lane 6), compared with the levels in the absence of caspase-3 (Fig. 4B, lane 3). However, co-transfecting the vIRF-2 and caspase-3 expression vectors resulted in IRF-3WT levels becoming undetectable within 24 h of poly(I:C) treatment (Fig. 4B, lane 12).
###end p 73
###begin p 74
###xml 131 137 131 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 184 195 184 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
###xml 241 250 241 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
###xml 293 302 293 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
The coincident transfection of the vIRF-2 and caspase-3 expression vectors also reduced the levels of both proteins substantially (Fig. 4B, compare vIRF-2 and pro-caspase-3 levels, in lanes 10-12, with the level of vIRF-2 without caspase-3, lanes 7-9, and pro-caspase-3 levels without vIRF-2, lanes 4-6). The data suggest a multiprotein complex forms between minimally vIRF-2, caspase-3, and IRF-3, leading to a reduction in the levels of each of them.
###end p 74
###begin p 75
###xml 95 101 95 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</italic>
###xml 265 271 265 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 287 289 287 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</italic>
###xml 381 387 381 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 390 401 390 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 10&#8211;12</italic>
###xml 482 488 482 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 635 641 635 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
###xml 666 668 666 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</italic>
vIRF-2 significantly inhibited caspase-3 activity against the Z-DEVD-aminoluciferin substrate (Fig. 4C, compare bars #6 and #10), providing further evidence against a pro-apoptotic role for vIRF-2. Moreover, reduced caspase-3/-7 activity in the presence of vIRF-2 (Fig. 4C, bars #9 and #10) is consistent with the reduced levels of caspase-3 in the presence of this viral protein (Fig. 4B, lanes 10-12). In these studies, the enzyme activities measured in the absence of caspase-3 (Fig. 4C, bars #1, #2, and #4) represent basal caspase-7 activities and therefore enable the contribution of ectopic caspase-3 activity to be determined (Fig. 4C, bars #3, #6, #9, and #10).
###end p 75
###begin title 76
Intracellular Localization of vIRF-2, IRF-3WT, and Caspase-3
###end title 76
###begin p 77
###xml 229 235 229 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 399 405 399 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 543 549 543 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 726 732 726 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 888 894 888 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 894 895 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1064 1070 1064 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1070 1071 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1073 1082 1073 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;9</italic>
###xml 1138 1144 1138 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1144 1145 1144 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1273 1280 1273 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figs. 3</xref>
###xml 1280 1281 1280 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1286 1287 1286 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1287 1288 1287 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1475 1481 1475 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1483 1484 1483 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1489 1490 1489 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Because IRF-3 stability in the presence of vIRF-2 protein expression was higher in caspase-3-deficient MCF-7 cells than in HEK293 cells, the distribution of these proteins in the breast adenocarcinoma cell line was investigated (Fig. 5). The studies were performed 16 h following poly(I:C) transfection, because after longer times in the presence of caspase-3, IRF-3 levels become undetectable (see Fig. 4B). The vIRF-2 protein assumed a diffuse cytoplasmic and nuclear distribution, with some concentration around the inner nuclear membrane (Fig. 5A). Upon activation of the antiviral response by poly(I:C) transfection, this distribution became more punctate with expression emphasized in the cytoplasm and not the nucleus (Fig. 5A). Conversely, IRF-3 redistributed to both the nuclear and cytoplasmic compartments from a predominantly cytoplasmic location upon poly(I:C) transfection (Fig. 5B), as described previously (23). When vIRF-2 and IRF-3 were co-expressed, IRF-3 was sufficiently abundant to be detected readily, consistent with the Western blot data (Fig. 4B, lanes 7-9), but its redistribution to the nucleus was minimized (Fig. 5C). These data are consistent with caspase-3-independent inhibition of IRF-3 transactivation by vIRF-2, as suggested previously (Figs. 3B and 4A). Both vIRF-2 and IRF-3, when expressed independently in MCF-7 cells, were sufficiently abundant to be identified as colocalizing with ectopic caspase-3, predominantly in the cytoplasm (Fig. 5, D and E, respectively).
###end p 77
###begin p 78
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF-3WT, vIRF-2, and caspase-3 co-localize in the cytoplasm.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 120 133 120 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel: vIRF-2</italic>
###xml 226 239 226 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel: vIRF-2</italic>
###xml 240 242 240 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 357 359 357 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 485 497 485 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel: IRF-3</italic>
###xml 606 618 606 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel: IRF-3</italic>
###xml 619 621 619 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 733 735 733 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 999 1001 999 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 1086 1087 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1240 1245 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 1271 1273 1271 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 1358 1359 1358 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1507 1512 1507 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 1538 1540 1538 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 1625 1626 1625 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1807 1812 1807 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3</italic>
###xml 1838 1840 1838 1840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IC</italic>
###xml 1960 1971 1960 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">merge panel</italic>
###xml 1973 1984 1973 1984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">white arrow</italic>
###xml 2037 2057 2037 2057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom row of panels</italic>
IRF-3WT, vIRF-2, and caspase-3 co-localize in the cytoplasm.A, vIRF-2 redistributes from the nucleus and the cytoplasm (panel: vIRF-2) to the cytoplasm following activation of the antiviral response by poly(I:C) transfection (panel: vIRF-2+IC). MCF-7 cells were transfected with the expression vector for Xpress-tagged vIRF-2. After 24 h they either were (+IC) or were not transfected with poly(I:C), fixed, and stained a further 16 h later. B, IRF-3 redistributes from the cytoplasm (panel: IRF-3) to the nucleus and the cytoplasm following activation of the antiviral response by poly(I:C) transfection (panel: IRF-3+IC). MCF-7 cells were transfected with the expression vector for FLAG-tagged IRF-3. After 24 h they either were (+IC) or were not transfected with poly(I:C), fixed, and stained a further 16 h later. C, vIRF-2 and IRF-3 co-localize in the cytoplasm. MCF-7 cells were co-transfected with the expression vectors for Xpress-tagged vIRF-2 and FLAG-tagged IRF-3. After 24 h they were (+IC) or were not transfected with poly(I:C) and fixed and stained a further 16 h later. D, vIRF-2 and caspase-3 co-localize in the cytoplasm. MCF-7 cells were co-transfected with the expression vectors for Xpress-tagged vIRF-2 and caspase-3 (CAS-3). After 24 h they were (+IC) or were not transfected with poly(I:C) and fixed and stained a further 16 h later. E, IRF-3 and caspase-3 co-localize in the cytoplasm. MCF-7 cells were cotransfected with the expression vectors for FLAG-tagged IRF-3 and caspase-3 (CAS-3). After 24 h they were (+IC) or were not transfected with poly(I:C) and fixed and stained a further 16 h later. F, vIRF-2, IRF-3, and caspase-3 co-localize in the cytoplasm. MCF-7 cells were co-transfected with the expression vectors for Xpress-tagged vIRF-2, FLAG-tagged IRF-3, and caspase-3 (CAS-3). After 24 h they were (+IC) or were not transfected with poly(I:C) and fixed and stained a further 16 h later. A region of co-localization in the merge panel (white arrow) was magnified, and the images are presented in the bottom row of panels.
###end p 78
###begin p 79
###xml 146 152 146 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 269 275 269 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 417 423 417 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 426 436 426 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom row</italic>
###xml 440 456 440 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">magnified images</italic>
When MCF-7 cells were co-transfected with vIRF-2, IRF-3 and caspase-3 expression vectors, the proteins they encode co-localized in the cytoplasm (Fig. 5F). Poly(I:C) transfection reduced IRF-3 protein to barely detectable levels, consistent with the Western blot data (Fig. 4B). Nevertheless, cytoplasmic co-localization of vIRF-2, IRF-3, and caspase-3 could still be determined in discrete regions of the cytoplasm (Fig. 5F, bottom row of magnified images) when sufficient IRF-3 levels were detectable.
###end p 79
###begin title 80
Endogenous IRF-3 Is Affected by vIRF-2 in the Same Way as Ectopic IRF-3WT
###end title 80
###begin p 81
The studies to date were performed with overexpressed, epitope-tagged ectopic IRF-3. We therefore examined the fate of endogenous IRF-3, to determine if it is regulated by vIRF-2 in the same way as ectopic IRF-3WT.
###end p 81
###begin p 82
###xml 127 133 124 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 133 134 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 144 148 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 150 151 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 157 158 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 267 273 264 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 273 274 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 284 288 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 290 291 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 297 298 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 341 347 338 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 347 348 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 495 501 489 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 501 502 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 512 516 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 518 519 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 525 526 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 608 614 602 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 614 615 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 761 767 752 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 767 768 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 778 782 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 784 785 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 791 792 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 906 912 897 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 912 913 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1124 1130 1112 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1130 1131 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1790 1796 1775 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1796 1797 1781 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1889 1895 1862 1868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1895 1896 1868 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2075 2081 2048 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 2081 2082 2054 2055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2567 2573 2540 2546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 2573 2574 2546 2547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 2576 2587 2549 2560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 2620 2621 2593 2594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2632 2640 2605 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 11</italic>
###xml 2645 2647 2618 2620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</italic>
###xml 2662 2669 2635 2642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 8</italic>
###xml 2674 2675 2647 2648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</italic>
First, activation of the full-length IFN-beta promoter by endogenous IRF-3 in response to poly(I:C) transfection was verified (Fig. 6A, compare bars #1 and #2). This activation was increased significantly following treatment with the pan caspase inhibitor Z-VAD-FMK (Fig. 6A, compare bars #2 and #3). These data are consistent with those of Fig. 2B, showing elevated levels of IRF-3WT in the presence of this inhibitor. The presence of vIRF-2 significantly inhibited IFN-beta promoter activity (Fig. 6A, compare bars #2 and #4), by >50%, consistent with the inhibitory activity of vIRF-2 on ectopic IRF-3WT (Fig. 1A). Treatment with Z-VAD-FMK in the presence of vIRF-2 completely restored IFN-beta promoter activity to the levels seen in the absence of vIRF-2 (Fig. 6A, compare bars #3 and #5). These data are consistent with the increase in ectopic IRF-3WT levels in the presence of vIRF-2 and Z-VAD-FMK (Fig. 2B). Because IFN-beta promoter activity is a surrogate marker for IRF-3 function, we then quantified active endogenous IRF-3 binding to its cognate oligonucleotide by ELISA, under similar experimental conditions (Fig. 6B). For these experiments an engineered derivative of HEK293 cells was studied, clone #3-9, in which all cells can be induced to express vIRF-2 (data not shown). Thus, this clonal cell line was stably transfected with a doxycycline-inducible vIRF-2 expression cassette (see "Experimental Procedures") and compared with isogenic empty vector (EV) cells. Both cell lines were treated with doxycycline to mitigate any effects of leaky vIRF-2 expression in the absence of doxycycline treatment. Measuring endogenous IRF-3 activity in clone #3-9 cells generated similar data to those obtained for IFN-beta promoter activity in transiently transfected HEK293 cells (Fig. 6A): vIRF-2 expression significantly inhibited endogenous IRF-3 activity by approximately50% (Fig. 6B, for DOX+DMSO-treated cells, compare IRF-3 activity in EV cells at 12 h with that in clone #3-9 cells). This inhibition was significantly repressed by the presence of Z-VAD-FMK (Fig. 6B, compare IRF-3 activity at 12 h in DOX+DMSO-treated clone #3-9 cells with that of DOX+Z-VAD-FMK-treated clone #3-9 cells). Moreover, the level of IRF-3 activity at 12 h in DOX+DMSO-treated EV cells is comparable to that in DOX+Z-VAD-FMK-treated clone #3-9 cells, suggesting the caspase inhibitor can almost completely restore endogenous IRF-3 activity in the presence of vIRF-2. Consistent with these data, dimeric IRF-3 levels in clone #3-9 cells increased with Z-VAD-FMK treatment (Fig. 6C, upper panel, compare the levels of dimeric (D) IRF-3 in lanes 11 and 12 with those in lanes 8 and 9).
###end p 82
###begin p 83
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Endogenous IRF-3 shares the same fate as ectopic IRF-3.</bold>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 387 397 384 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black bars</italic>
###xml 448 458 445 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">light bars</italic>
###xml 507 514 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 736 737 732 733 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 944 945 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 951 952 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 954 955 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 975 976 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 984 985 977 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1061 1066 1054 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z-VAD</italic>
###xml 1106 1109 1099 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;9</italic>
###xml 1199 1201 1192 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EV</italic>
###xml 1239 1242 1232 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOX</italic>
###xml 1342 1347 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z-VAD</italic>
###xml 1354 1355 1346 1347 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1471 1473 1462 1464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1579 1580 1568 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1582 1583 1571 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1603 1604 1592 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1612 1613 1601 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1687 1692 1676 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z-VAD</italic>
###xml 1764 1770 1753 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1770 1771 1759 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1868 1871 1857 1860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;9</italic>
###xml 1961 1963 1950 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EV</italic>
###xml 2001 2004 1990 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOX</italic>
###xml 2109 2110 2097 2098 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2263 2274 2249 2260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 2296 2314 2282 2300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower three panels</italic>
###xml 2352 2353 2338 2339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2370 2371 2356 2357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 2544 2545 2527 2528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2860 2870 2840 2850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black bars</italic>
###xml 2921 2931 2901 2911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">light bars</italic>
###xml 2980 2987 2960 2967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 3130 3141 3110 3121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAS-3 siRNA</italic>
###xml 3180 3193 3160 3173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control siRNA</italic>
###xml 3451 3452 3428 3429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 3454 3455 3431 3432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3465 3466 3442 3443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3468 3469 3445 3446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3488 3489 3465 3466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 3497 3498 3474 3475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 3600 3603 3577 3580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;9</italic>
###xml 3693 3695 3670 3672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EV</italic>
###xml 3728 3731 3705 3708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOX</italic>
###xml 3832 3833 3808 3809 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 3949 3951 3924 3926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 4054 4055 4027 4028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 4061 4062 4034 4035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 4064 4065 4037 4038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 4085 4086 4058 4059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Endogenous IRF-3 shares the same fate as ectopic IRF-3.A, vIRF-2 inhibition of the transcriptional activity of the full-length IFN-beta promoter (p125-luc) reporter vector driven by endogenous IRF-3 is repressed by the caspase inhibitor Z-VAD-FMK. HEK293 cells were transiently co-transfected with p125-luc and the Xpress epitope-tagged vIRF-2-expressing plasmid, pcDNA4/vIRF-2 (vIRF-2; black bars), or the empty parental plasmid backbone, pcDNA4 (light bars). The pRLSV40 plasmid constitutively expressing Renilla luciferase was added as an internal control to which firefly luciferase levels were normalized. Twenty-four hours later, cells were treated for 30 min with either DMSO (as the vehicle negative control) or Z-VAD-FMK (10 mum) and then transfected with poly(I:C) (10 mug/ml). Luciferase activity was measured 12 h later. The data represent the mean (+/- S.D.) from one representative experiment of three performed independently (*, #, and +, p < 0.005, Student's t test). B, vIRF-2 inhibition of endogenous IRF-3 activity is repressed by Z-VAD-FMK (Z-VAD) treatment. The clone #3-9 cell line (#3-9) harboring doxycycline-inducible vIRF-2 and the negative control empty vector cell line (EV) were both treated with doxycycline (DOX) for 24 h. They were then treated with either DMSO (as the vehicle negative control) or Z-VAD-FMK (Z-VAD; 10 mum) and transfected with poly(I:C) (10 mug/ml) for the times indicated. IRF-3 activity was determined with the TransAMTM IRF-3 ELISA (Active Motif). The data represent the mean (+/- S.D.) of two independent experiments (* and #, p < 0.005, Student's t test). C, vIRF-2-accelerated decay of endogenous IRF-3 is repressed by Z-VAD-FMK (Z-VAD) treatment. This experiment was performed essentially as described for Fig. 6B, with the exception that IRF-3 levels were measured by Western blot. The clone #3-9 cell line (#3-9) harboring doxycycline-inducible vIRF-2 and the negative control empty vector cell line (EV) were both treated with doxycycline (DOX) for 24 h. They were then treated with either DMSO (as the vehicle negative control) or Z-VAD-FMK (10 mum) and transfected with poly(I:C) (10 mug/ml) for the times indicated. Immunoblotting was performed on 10 mug of lysates separated either by native PAGE (upper panel) or denaturing PAGE (lower three panels). Native PAGE enabled IRF-3 dimeric (D) and monomeric (M) forms to be detected with anti-IRF-3 antibody. Aliquots of the same lysates were analyzed by denaturing PAGE to quantify total IRF-3, c-Myc-tagged vIRF-2, and beta-actin. D, vIRF-2 inhibition of the transcriptional activity of the full-length IFN-beta promoter (p125-luc) reporter vector driven by endogenous IRF-3 is repressed by caspase-3 siRNA. HEK293 cells were transiently co-transfected with p125-luc and the Xpress epitope-tagged vIRF-2-expressing plasmid, pcDNA4/vIRF-2 (vIRF-2; black bars), or the empty parental plasmid backbone, pcDNA4 (light bars). The pRLSV40 plasmid constitutively expressing Renilla luciferase was added as an internal control to which firefly luciferase levels were normalized. At the same time, either siRNA for caspase-3 (CAS-3 siRNA) or negative control scrambled siRNA (Control siRNA) was transfected. Twenty-four hours later, cells were transfected with poly(I:C) (10 mug/ml), and luciferase activity was measured 12 h later. The data represent the mean (+/- S.D.) from one representative experiment of three performed independently (* and #, p < 0.005; +, p < 0.05, Student's t test). E, measuring endogenous IRF-3 activity in the presence of vIRF-2 and MG132. The clone #3-9 cell line (#3-9) harboring doxycycline-inducible vIRF-2 and the negative control empty vector cell line (EV) were treated with doxycycline (DOX) for 24 h. They were then treated with either DMSO (as the vehicle negative control) or MG132 (10 mum) and transfected with poly(I:C) (10 mug/ml) for the times indicated. IRF-3 activity was determined with the TransAMTM IRF-3 ELISA (Active Motif). The data represent the mean (+/- S.D.) of two independent experiments (*, #, and +, p < 0.005, Student's t test).
###end p 83
###begin p 84
###xml 182 188 182 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 344 350 338 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 350 351 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 361 365 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 367 368 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 374 375 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 451 457 445 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 457 458 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 468 472 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 474 475 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 481 482 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 507 513 501 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 513 514 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 761 767 755 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 767 768 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 812 816 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 818 819 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 825 826 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 1111 1117 1099 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1117 1118 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1128 1132 1116 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 1134 1135 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1141 1142 1129 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 1208 1214 1196 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1214 1215 1202 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
To verify the effects of Z-VAD-FMK on endogenous IRF-3 involved caspase-3, the effect of caspase-3 siRNA on endogenous IRF-3 was determined. Essentially, the experiment presented in Fig. 3B was repeated, but IFN-beta promoter activity was measured. As expected, IFN-beta promoter activity was inhibited significantly by the presence of vIRF-2 (Fig. 6D, compare bars #2 and #4). However, this inhibition was significantly repressed by caspase-3 siRNA (Fig. 6D, compare bars #4 and #5). Thus, as for IRF-3WT (Fig. 3B), inhibition of endogenous IRF-3 transactivation by vIRF-2 was significantly mitigated by down-regulating caspase-3. Mitigation was not complete though, as measured by comparing the level of promoter activity achieved with caspase-3 siRNA alone (Fig. 6D, compare the IFN-beta promoter activity in bars #3 and #5), suggesting vIRF-2 might also inhibit endogenous IRF-3 activity by a caspase-3-independent mechanism. Furthermore, even in the absence of vIRF-2, there is modest, but significantly increased, IFN-beta promoter activity in the presence of caspase-3 siRNA compared with control siRNA (Fig. 6D, compare bars #2 and #3). This pattern is consistent with that seen for ectopic IRF-3WT (Fig. 3B), suggesting caspase-3 contributes to the negative regulation of IRF-3 activity even in the absence of vIRF-2.
###end p 84
###begin p 85
###xml 186 192 186 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 253 259 253 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 417 423 405 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 423 424 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 567 573 555 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 573 574 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 703 709 691 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 709 710 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 940 946 928 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 946 947 934 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
Finally, we verified that inhibition of the proteasome does not obviate vIRF-2-mediated inhibition of endogenous IRF-3 transactivation, as suggested from our studies of ectopic IRF-3WT (Fig. 2A). Again IRF-3 activity was quantified by functional ELISA (Fig. 6E). First, when comparing clone #3-9 and EV cells treated with doxycycline, IRF-3 activity was suppressed by approximately50% in the vIRF-2 expressing cells (Fig. 6E, compare IRF-3 activity at 12 h from EV cells treated with DOX+DMSO with that of clone #3-9 cells treated with DOX+DMSO), as described above (Fig. 6B). This vIRF-2 inhibition of IRF-3 activity was not reversed by MG132 treatment. Rather, inhibition was increased significantly (Fig. 6E, compare IRF-3 activity at 12 h from clone #3-9 cells treated with DOX+DMSO with that of clone #3-9 cells treated with DOX+MG132). This effect of MG132 in the presence of vIRF-2 is consistent with the suggestion from the data of Fig. 2A that vIRF-2 might recruit to IRF-3 either a protein or a protein complex responsible for IRF-3 decay that is normally targeted for degradation by the proteasome, but is therefore stabilized by MG132.
###end p 85
###begin p 86
###xml 160 166 160 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Moreover, treating EV cells with MG132 increased IRF-3 activity significantly, again consistent with the known proteasome involvement in normal IRF-3 turnover (Fig. 6E, compare IRF-3 activity at 12 h from EV cells treated with DOX+DMSO with that of EV cells treated with DOX+MG132).
###end p 86
###begin title 87
DISCUSSION
###end title 87
###begin p 88
###xml 495 502 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figs. 4</xref>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
The present study of the function of the KSHV vIRF-2 protein, in addition to elucidating the molecular mechanisms of a viral immune modulator, has identified a previously unrecognized cellular mechanism of negative feedback control of the IFN antiviral response. Our data reveal that in a cell in which this response is invoked by transfection of synthetic double-stranded RNA, a proteolytic process that involves caspase-3 activity depletes fully activated IRF-3. The studies with MCF-7 cells (Figs. 4 and 5) provide conclusive genetic proof for a mechanism of IRF-3 turnover involving caspase-3. This mechanism contributes to IRF-3 destabilization, along with the activity of the proteasome, to negatively regulate the antiviral response.
###end p 88
###begin p 89
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 41 47 <span type="species:ncbi:9606">humans</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 293 312 <span type="species:ncbi:154334">rhesus rhadinovirus</span>
KSHV is unique among viruses that infect humans in that it encodes a family of four vIRFs (41). Sequence comparisons indicate they share homology with cellular IRFs, from which they are likely to have been derived (17). The only other virus known to encode vIRFs is the KSHV-related non-human rhesus rhadinovirus (42, 43). However, all four of the KSHV vIRFs function in different ways, and vIRF-2 is not the only KSHV protein capable of suppressing the IFN antiviral response (see Ref. 16).
###end p 89
###begin p 90
###xml 339 345 339 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 410 416 410 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 566 572 566 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 718 724 718 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 724 725 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1610 1616 1606 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1618 1620 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1659 1665 1655 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1925 1927 1917 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1059 1082 <span type="species:ncbi:11176">Newcastle disease virus</span>
By accelerating the caspase-3-dependent process of IRF-3 turnover, the KSHV vIRF-2 protein functions as a catalyst in this IRF-3-degradative process, inhibiting IRF-3 transactivation and the concomitant antiviral response. The inhibition of IRF-3WT transactivation by vIRF-2, in MCF-7 cells in the absence of ectopic caspase-3 expression (Fig. 4A) and also in HEK293 cells during siRNA knockdown of caspase-3 (Fig. 3B), indicates that the viral protein can also repress IRF-3 activity independently of caspase-3; this observation was confirmed for endogenous IRF-3 (Fig. 6D). Confocal microscopy analyses suggest this caspase-3-independent activity may be due to vIRF-2 preventing IRF-3 redistribution to the nucleus (Fig. 5C). Indeed, vIRF-2 is likely multifunctional, as suggested from studies in the Pitha laboratory on the N-terminal exon-encoded protein (18, 19) that we refer to as vIRF-2x1 (17), to distinguish it from the two-exon-encoded full-length vIRF-2 protein of our present and previous (20) studies. Transactivation of the IFNA4 promoter upon Newcastle disease virus infection was inhibited by vIRF-2, likely through interacting with IRF-1 and post-translationally activated IRF-3, and/or the p300/CBP transcriptional coactivator (18). vIRF-2x1 also physically interacts with double-stranded RNA-activated protein kinase R (19). This interaction suppresses protein kinase R function, for example, reducing inhibition of eukaryotic translational initiation factor 2alpha activity by protein kinase R-mediated phosphorylation. Moreover, the interaction of vIRF-2 with IRF-1 identified by Burysek et al. (18) appears to be pleiotropic. Kirchhoff et al. identified positive regulatory IRF-1-dependent domains in the promoter of CD95 (Fas) ligand and recognized that vIRF-2 repressed transactivation of this promoter, perhaps through IRF-1 and NF-kappaB inhibition, in turn reducing activation-induced cell death (39).
###end p 90
###begin p 91
###xml 161 167 161 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 170 181 170 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 261 267 261 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 377 383 377 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figs. 1</xref>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
A mutant of IRF-3, IRF-3(5A), which homodimerizes upon phosphorylation of the serine residues in C-terminal site 1, but lacks phosphorylation targets in site 2 (Fig. 1A, lower panel), is still depleted in the absence of vIRF-2, but accumulates in its presence (Fig. 1E). Because IRF-3(2A) and IRF-3(2A5A) are incapable of homodimerization (27) and do not interact with vIRF-2 (Fig. 1D), we infer that dimerization is necessary for IRF-3 interaction with the viral protein. However, homodimerization and vIRF-2 interaction are insufficient for vIRF-2-accelerated decay of IRF-3, because IRF-3(5A) remains abundant in the presence of the viral protein (Figs. 1E and 2A). Thus, authentic phosphorylation of IRF-3 at both C-terminal sites is required for IRF-3 turnover involving caspase-3. These data suggest the caspase-3-dependent mechanism only operates on fully phosphorylated and functional IRF-3 that has undergone complete conformational rearrangement and is competent for transcriptional activation of cognate genes; constitutively expressed, non-activated IRF-3 is disregarded.
###end p 91
###begin p 92
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 256 256 256 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31"/>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 441 441 441 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46"/>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
Increasingly, the paradigm that caspases function only in a pro-apoptotic manner is being dispelled. Active caspases operate in multiple cellular processes, through both proteolytic and non-proteolytic activities, without activating apoptosis (see Refs. 30-32). These processes include cell differentiation, proliferation, and activation of inflammatory cytokines (44). Caspase-3 has non-apoptotic functions in various cell types (33, 34, 45-47), and transcription factors represent a class of non-apoptotic caspase targets (31), e.g. NFATc2 is cleaved by caspase-3 in apoptotic and non-apoptotic T cells (48).
###end p 92
###begin p 93
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 549 555 549 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 598 604 598 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 730 736 730 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1011 1018 1011 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figs. 1</xref>
###xml 1018 1019 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1025 1026 1025 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1427 1433 1427 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1476 1483 1476 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
The type I IFN-driven antiviral response can inhibit cell growth by blocking proliferation and inducing apoptosis, and it can enhance the adaptive immune response (see Ref. 1). Recent reports suggest IRF-3 itself is pro-apoptotic, providing cell death as a strategy to inhibit persistent virus infection (37). The mechanism may depend on the induction of expression of the pro-apoptotic protein, Noxa, because IRF-3 transactivates the gene encoding this protein (38). Our work has revealed caspase-3 inhibits IRF-3 by contributing to its depletion (Fig. 3) and concomitant functional inactivation (Fig. 6) and that vIRF-2 inhibits caspase-3/-7 function, as measured by cleavage of the luminogenic substrate Z-DEVD-aminoluciferin (Fig. 4C). These data suggest that vIRF-2 might sequester caspase-3 to augment IRF-3 decay, either directly or through recruitment of a protease that is in turn activated by caspase-3 and then degrades the vIRF-2/caspase-3 complex. This possibility is also supported by the data of Figs. 1E and 2A, in which the decay of incompletely activated IRF-3(5A) is inhibited by the presence of vIRF-2. We interpret this observation as IRF-3 being recruited by vIRF-2 to a caspase-3-containing complex, but the conformation of IRF-3(5A) is not amenable to its turnover by the complex. Certainly, in the context of the KSHV-infected cell, vIRF-2 expression kinetics are consistent with such a role: Krishnan et al. described vIRF-2 expression within 2 h of de novo KSHV infection (49).
###end p 93
###begin p 94
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 901 901 901 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51"/>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
Hence, vIRF-2 catalyzes caspase-3-mediated decay of IRF-3, functioning as a putative platform to recruit IRF-3 and caspase-3 and directing the proteolytic enzyme to initiate IRF-3 degradation. Whether caspase-3 acts either directly on IRF-3 to effect its depletion or, more likely, activates a proteolytic enzyme that then acts on IRF-3 remains to be established. Even if, in the KSHV-infected cell, the augmentation of this IRF-3 decay through sequestration of caspase-3 by vIRF-2 resulted in apoptosis, a panoply of anti-apoptotic KSHV factors, including vIRF-2 itself (39), would be expected to counteract it and prevent progression (16). Indeed, different KSHV proteins repress other aspects of the type I IFN-driven antiviral response. For example, the KSHV K3 and K5 proteins down-regulate cell surface expression of major histocompatibility class I molecules by augmenting their endocytosis (50-52; see Ref. 53).
###end p 94
###begin p 95
In conclusion, our work reveals a cellular process for terminating IRF-3 transactivation, not previously appreciated, and a new mechanism of virus evasion of the IFN response.
###end p 95
###begin title 96
Supplementary Material
###end title 96
###begin title 97
Supplemental Data
###end title 97
###begin p 98
This work was supported by the Medical Research Council (Grant G0400408) and Cancer Research UK (Grant C7934) (to D. J. B.).
###end p 98
###begin p 99
###xml 0 0 0 0 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 0 0 0 0 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
 The on-line version of this article (available at ) contains .
###end p 99
###begin p 100
###xml 28 31 28 31 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">IFN</term>
###xml 31 41 31 41 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="101">interferon</p>
###xml 31 41 31 41 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="101">interferon</p></def>
###xml 28 41 28 41 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">IFN</term><def><p textid="101">interferon</p></def></def-item>
###xml 41 44 41 44 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">IRF</term>
###xml 44 65 44 65 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="102">IFN regulatory factor</p>
###xml 44 65 44 65 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="102">IFN regulatory factor</p></def>
###xml 41 65 41 65 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">IRF</term><def><p textid="102">IFN regulatory factor</p></def></def-item>
###xml 65 69 65 69 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">KSHV</term>
###xml 69 106 69 106 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="103">Kaposi sarcoma-associated herpesvirus</p>
###xml 69 106 69 106 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="103">Kaposi sarcoma-associated herpesvirus</p></def>
###xml 65 106 65 106 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">KSHV</term><def><p textid="103">Kaposi sarcoma-associated herpesvirus</p></def></def-item>
###xml 106 108 106 108 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">KS</term>
###xml 108 122 108 122 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="104">Kaposi sarcoma</p>
###xml 108 122 108 122 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="104">Kaposi sarcoma</p></def>
###xml 106 122 106 122 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">KS</term><def><p textid="104">Kaposi sarcoma</p></def></def-item>
###xml 122 126 122 126 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">vIRF</term>
###xml 126 135 126 135 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="105">viral IRF</p>
###xml 126 135 126 135 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="105">viral IRF</p></def>
###xml 122 135 122 135 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">vIRF</term><def><p textid="105">viral IRF</p></def></def-item>
###xml 135 139 135 139 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">PARP</term>
###xml 139 184 139 184 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="106">poly(adenosine diphosphate-ribose) polymerase</p>
###xml 139 184 139 184 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="106">poly(adenosine diphosphate-ribose) polymerase</p></def>
###xml 135 184 135 184 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">PARP</term><def><p textid="106">poly(adenosine diphosphate-ribose) polymerase</p></def></def-item>
###xml 184 185 184 185 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">Z</term>
###xml 185 202 185 202 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="107">benzyloxycarbonyl</p>
###xml 185 202 185 202 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="107">benzyloxycarbonyl</p></def>
###xml 184 202 184 202 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">Z</term><def><p textid="107">benzyloxycarbonyl</p></def></def-item>
###xml 202 205 202 205 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">FMK</term>
###xml 205 224 205 224 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="108">fluoromethyl ketone</p>
###xml 205 224 205 224 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="108">fluoromethyl ketone</p></def>
###xml 202 224 202 224 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">FMK</term><def><p textid="108">fluoromethyl ketone</p></def></def-item>
###xml 224 226 224 226 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">EV</term>
###xml 226 238 226 238 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="109">empty vector</p>
###xml 226 238 226 238 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="109">empty vector</p></def>
###xml 224 238 224 238 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">EV</term><def><p textid="109">empty vector</p></def></def-item>
###xml 238 243 238 243 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">siRNA</term>
###xml 243 265 243 265 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="110">small interference RNA</p>
###xml 243 265 243 265 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="110">small interference RNA</p></def>
###xml 238 265 238 265 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">siRNA</term><def><p textid="110">small interference RNA</p></def></def-item>
###xml 265 270 265 270 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">ELISA</term>
###xml 270 304 270 304 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="111">enzyme-linked immunosorbent assay.</p>
###xml 270 304 270 304 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="111">enzyme-linked immunosorbent assay.</p></def>
###xml 265 304 265 304 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">ELISA</term><def><p textid="111">enzyme-linked immunosorbent assay.</p></def></def-item>
###xml 28 304 28 304 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">IFN</term><def><p textid="101">interferon</p></def></def-item><def-item><term id="G2">IRF</term><def><p textid="102">IFN regulatory factor</p></def></def-item><def-item><term id="G3">KSHV</term><def><p textid="103">Kaposi sarcoma-associated herpesvirus</p></def></def-item><def-item><term id="G4">KS</term><def><p textid="104">Kaposi sarcoma</p></def></def-item><def-item><term id="G5">vIRF</term><def><p textid="105">viral IRF</p></def></def-item><def-item><term id="G6">PARP</term><def><p textid="106">poly(adenosine diphosphate-ribose) polymerase</p></def></def-item><def-item><term id="G7">Z</term><def><p textid="107">benzyloxycarbonyl</p></def></def-item><def-item><term id="G8">FMK</term><def><p textid="108">fluoromethyl ketone</p></def></def-item><def-item><term id="G9">EV</term><def><p textid="109">empty vector</p></def></def-item><def-item><term id="G10">siRNA</term><def><p textid="110">small interference RNA</p></def></def-item><def-item><term id="G11">ELISA</term><def><p textid="111">enzyme-linked immunosorbent assay.</p></def></def-item></def-list>
The abbreviations used are: IFNinterferonIRFIFN regulatory factorKSHVKaposi sarcoma-associated herpesvirusKSKaposi sarcomavIRFviral IRFPARPpoly(adenosine diphosphate-ribose) polymeraseZbenzyloxycarbonylFMKfluoromethyl ketoneEVempty vectorsiRNAsmall interference RNAELISAenzyme-linked immunosorbent assay.
###end p 100
###begin p 101
interferon
###end p 101
###begin p 102
IFN regulatory factor
###end p 102
###begin p 103
Kaposi sarcoma-associated herpesvirus
###end p 103
###begin p 104
Kaposi sarcoma
###end p 104
###begin p 105
viral IRF
###end p 105
###begin p 106
poly(adenosine diphosphate-ribose) polymerase
###end p 106
###begin p 107
benzyloxycarbonyl
###end p 107
###begin p 108
fluoromethyl ketone
###end p 108
###begin p 109
empty vector
###end p 109
###begin p 110
small interference RNA
###end p 110
###begin p 111
enzyme-linked immunosorbent assay.
###end p 111
###begin title 112
Acknowledgments
###end title 112
###begin p 113
We thank John Hiscott (Lady Davis Institute for Medical Research, Canada), Reiner U. Jaanicke (University of Dusseldorf, Germany), Takashi Fujita (Kyoto University, Japan), and Gemma Kelly, Claire Shannon-Lowe, and Jianmin Zuo (University of Birmingham) for generously providing reagents. Martin Rowe kindly provided reagents and helpful comments on the manuscript and reagents. The authors acknowledge the helpful suggestions of Roger Grand.
###end p 113
###begin title 114
REFERENCES
###end title 114

